HighVista Strategies »

Evolus shares owned by HighVista Strategies

Quarter-by-quarter ownership of Evolus (EOLS) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Evolus

Tip: Access up to 7 years of quarterly data

All positions including Evolus held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evolus by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 226k 6.14
2025-06-30 $535k 58k 9.21

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Evolus

Nantahala Capital Management
Tang Capital Management
BlackRock
Caligan Partners
Vanguard Group
Frazier Life Sciences Management
Millennium Management
Stonepine Capital Management
State Street Corporation
Eversept Partners
Soleus Capital Management
Geode Capital Management
D. E. Shaw & Co
Rice Hall James & Associates
Nuveen

View all funds holding Evolus